Literature DB >> 10891347

Expression and characterization of the N- and C-terminal ATP-binding domains of MRP1.

A Kern1, F Felföldi, B Sarkadi, A Váradi.   

Abstract

The His(6)-tagged N- and C-terminal nucleotide binding (ATP Binding Cassette, ABC) domains of the human multidrug resistance associated protein, MRP1, were expressed in bacteria in fusion to the bacterial maltose binding protein and a two-step affinity purification was utilized. Binding of a fluorescent ATP-analogue occurred with micromolar dissociation constants, MgATP was able to inhibit the ATP-analogue binding with 70 and 200 micromolar apparent inhibition constants, while AMP was nearly ineffective. Both MRP1 nucleotide binding domains showed ATPase activities (V(max) values between 5-10 nmoles/mg protein/min), which is fifty to hundred times lower than that of parent transporter. The K(M) value of the ATP hydrolysis by the nucleotide binding domains were 1.5 mM and 1.8 mM, which is similar to the K(M) value of the native or the purified and reconstituted transporter, N-ethylmaleinimide and A1F(4) inhibited the ATPase activity of both nucleotide binding domains. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10891347     DOI: 10.1006/bbrc.2000.3040

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Remodelling of the SUR-Kir6.2 interface of the KATP channel upon ATP binding revealed by the conformational blocker rhodamine 123.

Authors:  Eric Hosy; Renaud Dérand; Jean Revilloud; Michel Vivaudou
Journal:  J Physiol       Date:  2007-05-17       Impact factor: 5.182

2.  Biochemical characterization and NMR studies of the nucleotide-binding domain 1 of multidrug-resistance-associated protein 1: evidence for interaction between ATP and Trp653.

Authors:  Odile Ramaen; Sandrine Masscheleyn; Francis Duffieux; Olivier Pamlard; Marine Oberkampf; Jean-Yves Lallemand; Véronique Stoven; Eric Jacquet
Journal:  Biochem J       Date:  2003-12-15       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.